Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study
2014 ◽
Vol 4
(Suppl 1)
◽
pp. A25.2-A25
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8145-8145
2000 ◽
Vol 6
(4)
◽
pp. 326-329
◽
2003 ◽
Vol 1
◽
pp. OC004-OC004
◽
2003 ◽
Vol 1
(9)
◽
pp. 1906-1913
◽